Karyopharm Therapeutics Inc. (KPTI): R&D Expense
$125.62M
Year ended 2025-12-31
$120.97M
Trailing 12 months to 2026-06-30
-5.5%
3-year compound annual growth
-3.6%
5-year compound annual growth
+2.5%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $125.62M | -12.3% | 2026-02-13, From 2025-01-01 |
| 2024-12-31 | $143.23M | +3.2% | 2026-02-13, From 2024-01-01 |
| 2023-12-31 | $138.75M | -6.7% | 2026-02-13, From 2023-01-01 |
| 2022-12-31 | $148.66M | -7.6% | 2025-02-19, From 2022-01-01 |
| 2021-12-31 | $160.84M | +6.6% | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | $150.81M | +23.3% | 2023-02-17, From 2020-01-01 |
| 2019-12-31 | $122.34M | -24.2% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $161.37M | +50.4% | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | $107.27M | +23.4% | 2020-02-26, From 2017-01-01 |
| 2016-12-31 | $86.94M | -11.1% | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | $97.74M | +62.6% | 2018-03-15, From 2015-01-01 |
| 2014-12-31 | $60.13M | +111.3% | 2017-03-16, From 2014-01-01 |
| 2013-12-31 | $28.45M | +101.9% | 2016-03-15, From 2013-01-01 |
| 2012-12-31 | $14.10M | +63.5% | 2015-03-13, From 2012-01-01 |
| 2011-12-31 | $8.62M | n/a | 2014-03-21, From 2011-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Karyopharm Therapeutics Inc. (KPTI) | 2025-12-31 | $125.62M | -12.3% |
| Elite Pharmaceuticals Inc (ELTP) | 2026-03-31 | $5.74M | -27.9% |
| Macrogenics Inc (MGNX) | 2025-12-31 | $147.17M | -16.9% |
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | $12.43M | -25.5% |
| Liquidia Corp (LQDA) | 2025-12-31 | $39.28M | -17.9% |
| Lifecore Biomedical, Inc. (LFCR) | 2025-05-25 | $8.26M | -3.7% |
| Xencor Inc (XNCR) | 2025-12-31 | $239.43M | +5.2% |
| Syndax Pharmaceuticals Inc (SNDX) | 2025-12-31 | $258.78M | +7.1% |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | $32.78M | -3.8% |
Compare KPTI, ELTP, MGNX, HRTX side by side · Screen every company in Pharmaceutical Preparations ↗